Clinical Scorecard: Factors Influencing the Adoption of Metabolic Bariatric Surgery: A Study of Sociodemographic, Healthcare, and Clinical Variables
At a Glance
Category
Detail
Condition
Key Mechanisms
Metabolic bariatric surgery (MBS) leads to substantial weight loss, improves glycemic control, and reduces the risk of obesity-associated cancer and mortality.
Target Population
Care Setting
Key Highlights
Approximately 40.3% of US adults are obese.
MBS uptake is low at about 1% of clinically eligible population annually.
Disparities in MBS uptake exist across demographic and socioeconomic factors.
GLP-1 receptor agonists are increasingly prescribed, impacting MBS uptake.
Ongoing research is needed on the combination of GLP-1 RAs and MBS.
Evidence gap exists regarding GLP-1 RAs in individuals with class III obesity.
Guideline-Based Recommendations
Diagnosis
Use ICD-10 codes E66 and Z68.35 to Z68.45 for obesity diagnosis.
Management
Consider MBS for individuals with a BMI of at least 35.0.
Monitoring & Follow-up
Assess comorbid conditions and medication use during the baseline period.
Risks
Underdiagnosis of obesity and lack of physician education contribute to low MBS uptake.
Consider the implications of GLP-1 RAs on MBS uptake.
Patient & Prescribing Data
Individuals with employer-based insurance and an incident obesity diagnosis.
GLP-1 RAs have shown significant weight loss but may not fully address obesity in patients with higher BMIs; further research is needed.
Clinical Best Practices
Utilize specific machine learning methods to identify factors influencing MBS uptake.
Ensure continuous enrollment for 12 months before and after the index date for accurate assessment.
